Nexalin regains compliance with Nasdaq minimum bid price rule

Nexalin Technology, Inc.

Received notice from Nasdaq on Oct. 31, 2024, confirming compliance with Rule 5550(a)(2).
Regaining compliance removes the risk of delisting from the Nasdaq exchange.
CEO Mark White highlighted the milestone for shareholder value and clinical progress.
Company trades under symbols NXL and NXLIW on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.